NEWS & EVENTS
Company News
Press Release
For Immediate Release
June 4, 2008
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Brian Bogie/Laura Coluci
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
Leerink Swann Appoints Institutional Investor All-America Research Analysts: Frederick Wise, CFA for Medical Supplies and Devices and Jason Gurda, CFA for Health Care Facilities
Boston, MA – June 4, 2008 - Healthcare investment bank Leerink Swann announced that Frederick Wise, CFA and Jason Gurda, CFA have joined the Firm, Wise as Managing Director covering the Medical Supplies and Devices industry and Gurda as Director covering the Health Care Facilities industry.
Mr. Wise was previously a Senior Managing Director and Medical Supplies and Devices analyst with Bear Stearns. For the past eleven years, he has been a member of the Institutional Investor All-America Research Team, most recently with a #3 ranking in the 2007 poll. Wise was also ranked #4 in the 2007 Greenwich Associates U.S. Equity Analysts poll. Prior to joining Bear Stearns, Wise served as an analyst at Kidder, Peabody & Co. and Forbes, Inc.
Additionally, Wise will be joined by two of his associates from his II Award-Winning Research Team, Danielle Antalffy and Miroslava Minkova.
Mr. Gurda was previously an Equity Research Analyst with Bear Stearns for the past six years. He was ranked #3 in the 2007 Institutional Investor All-America Research Team poll and ranked #4 in the 2007 Greenwich Associates U.S. Equity Analysts poll. Prior to joining Bear Stearns, Gurda served as a research associate with Brean Murray & Co., Gruntal & Co. and Prudential Securities.
"We are extremely fortunate to add two Institutional Investor ranked analysts like Rick and Jason to our dedicated healthcare research platform" said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. "Each has earned prominent recognition by providing cutting-edge insights for clients who are making critical investment decisions. Their industry knowledge will further enhance our ability to deliver the highest quality healthcare research.”
John L. Sullivan, CFA, Director of Research, added, “Both Rick and Jason have established themselves as leaders within their sectors. Rick has been a perennial standout in the Medical Supplies and Devices category, and Jason has quickly gained a reputation for innovative thinking and idea generation in Health Care Facilities. We welcome them as outstanding additions to our team.”
These additions to the Firm highlight the momentum that Leerink Swann has built through its unique knowledge platform and exclusive focus on healthcare. Wise and Gurda will serve to enhance Leerink Swann’s ability to help healthcare companies devise and execute superior growth strategies, while enabling the Firm’s clients to make well-informed healthcare investment decisions.
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. For the past seven years, Institutional Investor has named Leerink Swann Best of the Boutiques in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC.
- END -